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The diagnosis and management of primary cutaneous melanoma have traditionally relied on clinical and histological
characteristics. Nevertheless, in recent years there has been a signiﬁcant growth in the usage of ultrasound for studying the
cutaneous layers. Thus, the present paper focuses on the primary lesion, its sonographic characteristics, the potential beneﬁts
of early imaging, and the new developments on the ultrasound ﬁeld applied to cutaneous melanoma.
1.Introduction
Cutaneous malignant melanoma constitutes 4 to 11% of all
skin cancers but is responsible for more than 75% of skin
cancer-related deaths producing more than 8000 deaths per
year in the United States [1]. To date the diagnosis is clinical,
and the usage of ultrasound in the study of cutaneous mel-
anoma has been focused more on the locoregional staging
than on the primary lesion, and the prognosis being mainly
assessed by clinical and histological features.
The staging of melanoma is mostly based on the Breslow
classiﬁcation that relies on sequential tumor inﬁltration
(depth) by histology within the diﬀerent cutaneous layers,
providing a measurement of the microscopic invasion from
the stratum granulosum of the epidermis to the deepest por-
tion of the tumor [2]. The Breslow index has been reported
to correlate well with the prognosis of the disease. Moreover,
according to the thickness of the primary tumor, important
decisions are taken such as the size of the excision and the
free margins or the requirement for a sentinel lymph node
procedure.
Nevertheless, there are controversial reports about the
appropriate size of the excision that should be performed on
melanoma. Hence, a small (but potentially important) dif-
ference in overall survival between wide and narrow excision
margins has been reported that cannot be conﬁdently ruled
out. Literature has mentioned that recurrence-free survival
is favored with wide excision (Hazard Ratio 1.13; P = 0.06;
95%conﬁdenceinterval0.99to1.28)buttheresultshavenot
reached statistical signiﬁcance (P<0.05 level). Furthermore,
randomized trial evidence seems to be insuﬃcient to address
optimal excision margins for primary cutaneous melanoma
[3].
Reports on recurrence rates in melanoma have shown a
wide range depending on the stage of the primary tumor;
thus, they can vary from 7.1% in stage I to 51% in stage III
[4]. Moreover, older patients with thicker tumors and angi-
olymphatic invasion appear to be at higher risk for local and
in-transit recurrence [5]. Hence, the appearance of in-transit
metastasis seems to be linked to the biological characteristics
of the tumor cells rather than an inﬂuence of the surgical
technique [6].
Recent advances in ultrasound technology have allowed
observation of the cutaneous layers with good resolution.
Thus, using multichanneled color Doppler machines, with
variable frequency probes that reach frequencies ≥15MHz,
the echostructure of the skin layers can be clearly deﬁned
[7]. Furthermore, in spite of the limitations of sonography to
detect pigments such as melanin, the noninvasive assessment
of the characteristics of the primary tumor, such as thickness
andbloodﬂow,maycontributetothemodiﬁcationofcritical
management decisions.
The literature has sequentially increased sonographic
information about primary cutaneous melanoma lesions [7–
9]. The ﬁrst sonographic reports on melanoma were per-













Figure 1: Melanoma in situ. (a) Ultrasound (transverse view, plantar region) shows lack of detectable solid tumor. Notice the partial
loss of the normal bilaminar hyperechoic pattern of the plantar epidermis in parts of the lesion (arrows). (b) Color Doppler ultrasound
demonstrates lack of hypervascularity at the lesional site. (c) Histology (HE × 100, acral skin, courtesy of Dr. Laura Carre˜ no, Department
of Pathology, Hospital Clinico Universidad Chile, University of Chile, Santiago, Chile) shows atypical nests of melanocytic cells within the
epidermis (in situ). At the dermis there are some melanophages (arrows). Abbreviations: sc: stratum corneum; d: dermis; st: subcutaneous
tissue.
ﬁxed high-frequency probes that go from 20 to 100MHz.
The usage of these machines provided valuable information
that showed a good correlation between sonometry and
histometry (r = 0.88), with a mean diﬀerence of 0.39mm
(relative diﬀerence 28%). This report has also shown that
tumors measuring between 0.55 and 0.95mm thick were
incorrectly classiﬁed according to histology in 34%. Nev-
ertheless, thicker tumors that measured between 1.30 and
1.70mm were incorrectly classiﬁed in 50% of cases [10]. The
latterresultsmayperhapsberelatedtothelowpenetrationof
these ﬁxed frequency ultrasound machines (approximately
6mmat20MHz,3mmat75MHz,and1mmat100MZ)
[11, 12]. This point could be relevant since the skin presents
variable thickness of its layers according to the corporal
region; thus, only the dermis could measure more than
3.0mm (thickness) in normal individuals such as, for exam-
ple, in the dorsal thoracic region [7]. Nevertheless, the usage
of 75MHz ﬁxed high-frequency ultrasound for observing
thin melanomas that presented a mean histological Breslow
thickness of 0.4mm (22 were in situ) showed a high corre-
lation (Pearson’s r = 0.908, P<0.001) with a median per-
centage error up to 13% with the histological Breslow
thickness. Sonographic measurements in this report were
considered as highly reliable for invasive melanoma, even in
the presence of lymphocytic inﬁltration or nevus [12].
On the other hand, using multichanneled color Doppler
ultrasound equipment with variable frequency probes that
go from 10 to 15MHz, it has already been reported that
ultrasound is capable of diﬀerentiating melanomas meas-
uring < or >1mm of thickness, which is important for re-
quiring, for example, a sentinel lymph node procedure that
is indicated in melanomas measuring more than 1mm thick
[13, 14].
Thus, recognition of this vital depth information can
support the performance of “one-time” surgery in melano-
ma,wherethesizeoftheincisionandthefreemarginsaswell
as the sentinel lymph node procedure are planned with an
imaging support presurgically [15]. The use of sonography
as a “thickness discriminator” has shown high correlation
with histological results [16–18]. Nevertheless, sonographic
measurements can be slightly higher than histology because
they correspond to in vivo tissue without dehydration or
ﬁxation,andmayincludesubtumoralmononuclearinﬁltrate
and nest of nevus cells which cannot be diﬀerentiated sono-
graphically from melanoma cells [10]. This small diﬀerence
in the measurements has been reported to be much less than
the actual size of the extension used for assessing the free
margins that is usually used in melanoma surgery. Moreover,
using 12–15MHz frequency, the sensitivity and positive pre-












Figure 2: Melanoma primary tumor inﬁltrating dermis. (a) Ultrasound (grey scale, transverse view, dorsal region) shows oval-shaped
hypoechoic lesion (∗) that involves the dermis. The epidermis also appears more hyperechoic and thickened. (b) Color Doppler ultrasound
(transverse view) demonstrates increased blood ﬂow within the tumor that predominates at the bottom of the lesion (∗). (c) Histology
(HE × 4, courtesy of Dr. Laura Carre˜ no, Department of Pathology, Hospital Clinico Universidad Chile, University of Chile, Santiago,
Chile) demonstrates atypical melanocytic cells inﬁltrating epidermis and dermis. Prominent vessels are detected in the subtumoral area.
Abbreviations: e: epidermis; d: dermis; st: subcutaneous tissue; ∗: melanoma site.
1mm has been reported to be 92% and 95%, respectively
[18].
Although early stages can be successfully treated by
surgery, adjuvant therapies are used for managing advanced
states.Furthermore,exceptionstowidelocalexcisioninclude
cases where surgical excision may be cosmetically disﬁguring
or associated with increased morbidity and mortality. Thus,
there are several meta-analyses of randomized controlled tri-
als that have reported the impact of adjuvant interferon alfa
therapyformalignantmelanoma[19–23].Also,therearesys-
temic therapies such as cytokine therapy, chemotherapy, and
biochemotherapy. Additionally, cellular therapy, gene ther-
apy and targeted therapy are undergoing investigation [24].
Furthermore, the role of deﬁnitive or adjuvant radiotherapy
has largely been relegated to palliative measures. However,
the emerging clinical and radiobiological data suggest that
many types of eﬀective radiation therapy, such as intensity-
modulated radiotherapy for melanoma of the head and
neck,andadjuvantradiotherapyforselectedhigh-risk,node-
positive patients can improve outcomes [25]. Hence, these
nonsurgical treatments may also require noninvasive imag-
ing modalities for objective monitoring of the anatomical
changes invisible to the naked eye. Moreover, new applica-
tionsofultrasoundsuchassonodynamictherapy(SDT),that
use the energy of ultrasound and certain chemical photocat-
alystsensitizerssuchasTitaniumdioxide(TiO2),canbeused
tokillthecancerouscellsinmelanoma.Sofar,thissonication
procedure is performed by experimental devices but in the
future, perhaps, may be adapted to our usual machines [26].
2. Sonographic Characteristics of
the Primary Melanoma
Onsonography,earlylesionsusuallypresentovalorfusiform
shape and hypoechogenicity [27, 28]. Commonly, these le-
sions inﬁltrate the dermis and show increased blood ﬂow
withinthetumor.Nevertheless,caseswithinsitulesionsmay
not show detectable masses. In cases with ulcerations, the
epidermis may be irregular or discontinuous, and increased
echogenicity of the surrounding subcutaneous tissue may
alsobefound[9].Sincethetumorcanshowasymmetryinits
shape, the measurement of thickness should be performed at
the deepest point. When examining these lesions, it is rec-
ommended to apply a copious amount of gel on the skin
surface; thus we can observe the lesion without compressing
the vascularity that may present prominent low velocity arte-
rial vessels within the lesions, especially in bulky tumors.
Knowledge of the peak systolic arterial velocity of these ves-
sels (cm/sec) may provide an idea of the angiogenic power
of the tumor that can correlate with its metastatic poten-












and subcutaneous tissue. Notice the hypoechoic solid nodule besides the primary tumor that corresponds to a satellite metastasis (arrow).


















dermis and subcutaneous tissue, almost reaching the ﬂexor tendon (ﬂ) close to the second metatarsal bone (mtt). (b) Color Doppler
ultrasound shows highly increased blood ﬂow covering most parts of the lesion.
needle aspiration cytology have been reported as useful for
identifying sentinel nodes metastasis and reduce the need
for surgical sentinel nodes procedures. Moreover, peripheral
perfusionhasbeenmentionedasanearlysignofinvolvement
and of crucial importance to achieve a high identiﬁcation
rate of metastasis. Balloon shape and loss of central echoes
are indeed late signs of malignant nodal inﬁltration [29,
30]. When studying bulky melanomas, the use of lower
frequency probes can help to obtain the complete extension
of the tumor which may also require extended ﬁeld of view
capabilities.Ofthesettings,thepowerDopplerthatisusually
more sensitive for detecting slow ﬂow could be more useful
than the color Doppler mode. The lowest pulse repetition
frequencies (that do not cause aliasing or excessive reduction
of the frame rate) and the lowest wall ﬁlter and color gain,
below the noise threshold, are preferred to obtain better
quality images [9, 31] (Figures 1, 2, 3,a n d4).
Commonly close to the primary lesion, satellite lesions
(arising within 2cm fromthe primary tumor) may be found,
which may appear as hypoechoic solid masses in the sub-
cutaneous tissue, presenting variable degrees of vascularity
[9, 31] (Figure 3).
3.Contrast-EnhancedUltrasound
on Melanoma
Contrast enhanced ultrasound has been progressively more
used in the study of the primary lesion and the locoregional
metastases. The usage of contrast may support the nonsur-
gical treatment of the primary lesion and clarify a doubtful
cortical thickening at the lymph nodes [32, 33]. Moreover,
vascular density has already been correlated with metastatic
potential using color Doppler ultrasound. Thus, assessment
of the tumor perfusion characteristics is becoming an issue
in oncology. Furthermore, neovascularization is a prognostic
factor for metastasis equivalent to the Breslow index [33].
Therefore, an early provision of functional images of the
primary tumor can provide relevant information concerning
the usefulness of new targeted therapies and antiangiogenic
treatments, thereby allowing an early assessment of the ef-
fectiveness of the treatment [34, 35]. This functional analysis
of the tumoral perfusion relies on the acoustic properties of
the microbubbles that increase the signal-to-noise ratio and
the sensitivity to microvessel detection at higher levels than
the power Doppler [36].
4.Sonoelastography inCutaneousMelanoma
As yet, few reports that show the usefulness of sonoelas-
tography in cutaneous melanoma are available. To date, the
reports are mostly based on acoustooptical elastography
(AOE), an experimental imaging modality for quantifying
the mechanical behavior of skin lesions. The method relies
upon stimulating the tissue with a low-frequency acoustic
force and imaging the resulting strains in the tissue by meansRadiology Research and Practice 5
of quantifying the magnitude of the dynamic shift in a back-
reﬂected laser speckle pattern from the skin. The magnitude
of the shift reﬂects the local stiﬀness of the tissue, which
hasshownpromisingresultswhencomparingbenignmelan-
ocytic nevi with melanoma [37].
5. Conclusion
Ultrasound can be a reliable tool for assessing relevant char-
acteristics of the primary lesion such as depth and vascular-
ity. This imaging method is not intended to replace histology
but perhaps the anatomical information can provide a miss-
ing link between the clinical evaluation, and the later, biopsy
and treatments. Furthermore, this detailed data has the po-
tential to help with deciding on appropriate treatment and
therefore, may allow a one-time treatment, support an early
test of the eﬃcacy of a treatment, and perhaps help to de-
crease the recurrence rates. Nowadays, considering the fast
evolution of imaging technologies, the inclusion of imaging
modalities in the routine evaluation and classiﬁcation of
the primary tumors could be the next step to follow in the
management of melanomas.
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